Table of Content
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger and Acquisition Landscape
5.7 Upcoming trends
5.7.1 Market trends
5.7.2 Technological trends
5.7.3 Insurance & Regulations
5.7.4 Others
6. Global Intravenous Immunoglobulin (IVIg) Market by Type
6.1 IgA
6.1.1 IgA1
6.1.2 IgA2
6.2 IgD
6.3 IgE
6.4 IgG
6.5 IgM
7. Global Intravenous Immunoglobulin (IVIg) Market by Application
7.1 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
7.1.1 Progressive
7.1.2 Recurrent
7.1.3 Monophasic
7.2 Hypogammaglobulinemia
7.2.1 AGM1
7.2.2 AGM2
7.2.3 AGM3
7.2.4 AGM4
7.2.5 AGM5
7.2.6 AGM6
7.3 Multifocal Motor Neuropathy
7.4 Immunodeficiency diseases
7.4.1 X-linked agammaglobulinemia (XLA)
7.4.2 Common variable immunodeficiency (CVID)
7.2.4 Severe combined immunodeficiency
7.5 Primary Humoral Immunodeficiency
7.5.1 B cell (antibody) deficiencie
7.5.2 T cell deficiencies
7.5.3 Combination BT cell deficiencies
7.5.4 Defective phagocytes
7.5.5 Complement deficiencies
7.5.6 Unknown (idiopathic)
7.6 Myasthenia Gravis
7.6.1 Generalized myasthenia gravis
7.6.2 Ocular myasthenia gravis
7.6.3 Congenital myasthenia gravis
7.6.4 Transient neonatal myasthenia gravis
7.7 Guillain-Barre syndrome
7.7.1 Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP)
7.7.2 Miller Fisher syndrome (MFS)
7.7.3 Acute motor axonal neuropathy (AMAN)
7.7.4 Acute motor-sensory axonal neuropathy (AMSAN)
7.8 Kawasaki disease
7.9 ITP
7.9.1 Acute
7.9.2 Chronic
7.9 Others
8. Global Intravenous Immunoglobulin (IVIg) Market by Region
8.1 Introduction
8.2 America
8.2.1 North America
8.2.1.1 The US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.3 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 South Korea
8.4.5 Rest of Asia
8.5 Pacific
8.6 Middle East and Africa
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 Egypt
8.6.4 Rest of Middle East and Africa
9 Conclusion
9.1 Key findings
9.1.1 From CEO’s viewpoint
9.1.2 Unmet needs of the market
9.2 Key companies to watch
9.3 Prediction of medical robots industry
10 Appendix
